Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/25/2003WO2003078424A1 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
09/25/2003WO2003078334A1 Fresh water treatment plant and method for obtaining drinking water
09/25/2003WO2003078050A2 A building block forming a c-c bond upon reaction
09/25/2003WO2003078045A2 Microcapillary hybridization chamber
09/25/2003WO2003077998A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
09/25/2003WO2003077948A1 Preventives/remedies for myeloma tumor and method of diagnosing the same
09/25/2003WO2003077943A2 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound
09/25/2003WO2003077900A1 A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
09/25/2003WO2003077872A2 Cell surface tropomyosin as a target of angiogenesis inhibition
09/25/2003WO2003077870A2 New strains of mycoplasma hyorhinis as causative agents for autoimmune disease
09/25/2003WO2003077853A2 Immortal porcine cells
09/25/2003WO2003077851A2 Compounds and methods for analyzing the proteome
09/25/2003WO2003077841A2 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
09/25/2003WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003WO2003077761A1 Blood analyzer
09/25/2003WO2003077734A2 Methods of diagnosing the presence of trail
09/25/2003WO2003077648A2 Methods for the identification of herbicides and the modulation of plant growth
09/25/2003WO2003070738A3 Topiramate salts and compositions comprising and methods of making and using the same
09/25/2003WO2003067252A3 Electrochemical biosensor strip for analysis of liquid samples
09/25/2003WO2003067251A3 Device for performing cell assays
09/25/2003WO2003058196A3 Multianalyte molecular analysis using application-specific random particle arrays
09/25/2003WO2003050536A3 Methods and apparatus for separation of blood components
09/25/2003WO2003046153A3 The use of quantitative evolutionary trace analysis to determine functional residues
09/25/2003WO2003046001A3 Protein biopolymer markers predictive of insulin resistance
09/25/2003WO2003043487A3 Method of using a non-antibody protein to detect and measure an analyte
09/25/2003WO2003042411A3 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
09/25/2003WO2003042402A3 Agents that modulate immune cell activation and methods of use thereof
09/25/2003WO2003042245B1 Growth hormone variations in humans and their uses
09/25/2003WO2003040390A3 Protease assay for therapeutic drug monitoring
09/25/2003WO2003038724A9 Methods and apparatus for protein sequence analysis
09/25/2003WO2003038439A3 Functional identification of targets on tissues and cells
09/25/2003WO2003031977A3 Binding assay using a magnetic field
09/25/2003WO2003026394A3 Cathepsin g (ctsg) disruptions, compositions and methods relating thereto
09/25/2003WO2003014746A3 Method for identifying proteins with n-terminal n-myristoylation
09/25/2003WO2003012078A3 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
09/25/2003WO2003008976A3 Kit, zugehörige reagentien und methode zur diagnose von zoeliakie
09/25/2003WO2003006993A3 Gel compositions
09/25/2003WO2003006956A3 Cell enumeration
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003002108A3 Use of tyrosine kinase inhibitors for treating inflammatory diseases
09/25/2003WO2003001210A3 Retrovirus associated with myelodysplastic syndromes
09/25/2003WO2002102824A3 Method for specific fast detection of relevant bacteria in drinking water
09/25/2003WO2002100827A9 Method for increasing the survival of dopamine secreting cells
09/25/2003WO2002097059A9 Chromosome-based platforms
09/25/2003WO2002097049A3 Compositions and methods for binding agglomeration proteins
09/25/2003WO2002094439A3 System for cellular storage and genetic information retrieval
09/25/2003WO2002094287A3 Identifying parasitic fungi of the organism, and treatment thereof
09/25/2003WO2002092635A3 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
09/25/2003WO2002090929A3 Process for analyzing protein samples
09/25/2003WO2002088736A3 Prenatal diagnosis method on isolated foetal cell of maternal blood
09/25/2003WO2002088735A3 Method for depositing a spot of a product of interest, and use for isolating and/or determining an analyte
09/25/2003WO2002086473A3 Method and device for analysing cereals
09/25/2003WO2002085185A3 Hydrophilic diagnostic devices
09/25/2003WO2002082086A3 Detection of methicillin-resistant staphylococcus aureus (mrsa)
09/25/2003WO2002082082A3 Fluorescence polarization assay
09/25/2003WO2002080847A3 Use of tumor necrosis factor inhibitors to treat cardiovascular disease
09/25/2003WO2002077263A3 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
09/25/2003WO2002076482A3 USE OF IKK-β INHIBITORS AND METHOD FOR DISCOVERY OF SAID INHIBITORS
09/25/2003WO2002076383A3 Securin is required for chromosomal stability in human cells
09/25/2003WO2002072880A3 Method for detecting cytosine methylation patterns having high sensitivity
09/25/2003WO2002065086A3 Method and device for measuring the efficacy of a lubricating oil and uses thereof
09/25/2003WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89)
09/25/2003WO2002063004A3 G-protein coupled receptors
09/25/2003WO2002062135A3 Scce modified transgenic mammals and their use as models of human disease
09/25/2003WO2002061128A3 Method of determining a chemotherapeutic regimen based on ercc1 expression
09/25/2003WO2002055736A3 Antisense imaging of gene expression of the brain in vivo
09/25/2003WO2002048700A3 Method for classifying chemical substances according to olfactory characteristics
09/25/2003WO2002046419A3 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
09/25/2003WO2002044422A3 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
09/25/2003WO2002033393A3 Method and apparatus for analyzing mixtures of gases
09/25/2003WO2002031203A3 High throughput or capillary-based screening for a bioactivity or biomolecule
09/25/2003WO2002031146A3 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
09/25/2003WO2002030964A3 Comparative ligand mapping from mhc positive cells
09/25/2003WO2002026982A3 Secreted human proteins
09/25/2003WO2002024910A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
09/25/2003WO2002022874A3 Oligonucleotides for labeling oligonucleotide probes and proteins
09/25/2003WO2002022803A3 Peptide epitopes recognized by antigen specific cd4+ t lymphocytes
09/25/2003WO2002020846A3 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
09/25/2003WO2002018661A3 Methods for identifying novel therapeutic agents
09/25/2003WO2002014489A9 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
09/25/2003WO2002014361A3 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
09/25/2003WO2002005698A3 Method for extracting fluorophores from biological samples
09/25/2003WO2002005634A3 Transgenic animal and methods
09/25/2003WO2002004661A3 Methods for classifying nucleic acids and polypeptides
09/25/2003WO2002004433A3 Melanin concentrating hormone receptor ligands
09/25/2003US20030182682 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants
09/25/2003US20030182676 A reporter gene, the transcription of which is inducible by natural or synthetic molecule which modulate the activity of such reporter, is incorporated into the genome of the animal to produce nonhuman transgenic animal
09/25/2003US20030182673 Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto
09/25/2003US20030182669 Exposing a cell containing molecules (detectably labeled) involved in G-protein coupled receptor internalization, exposing the cell to a compound, detecting the location in the cell of the labeled molecule
09/25/2003US20030182668 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
09/25/2003US20030182667 Type iii allergic inflammation model animal
09/25/2003US20030182066 Method and processing gene expression data, and processing programs
09/25/2003US20030182061 Method and apparatus for simulating PVT parameters
09/25/2003US20030182013 Method for online characterisation of a moving surface and device therefor
09/25/2003US20030181826 Hydrophobic/hydrophilic sample collection tip
09/25/2003US20030181710 Death domain-containing receptor polynucleotides, polypeptides, and antibodies
09/25/2003US20030181706 Inflammation-associated polynucleotides
09/25/2003US20030181703 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181702 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181701 PRO polypeptides; fused to heterologous polypeptide sequences
1 ... 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 ... 3937